TY - JOUR
T1 - Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination
AU - Cannistraro, Vincent J.
AU - Taylor, John Stephen A.
N1 - Funding Information:
Funding for open access charge: National Institutes of Health (Grant CA40463).
PY - 2010/11
Y1 - 2010/11
N2 - Spontaneous deamination of cytosine to uracil in DNA is a ubiquitous source of C→T mutations, but occurs with a half life of ∼ 50000 years. In contrast, cytosine within sunlight induced cyclobutane dipyrimidine dimers (CPD's), deaminate within hours to days. Methylation of C increases the frequency of CPD formation at PyCG sites which correlate with C→T mutation hotspots in skin cancers. MeCP2 binds to mCG sites and acts as a transcriptional regulator and chromatin modifier affecting thousands of genes, but its effect on CPD formation and deamination is unknown. We report that the methyl CpG binding domain of MeCP2 (MBD) greatly enhances C=mC CPD formation at a TCmCG site in duplex DNA and binds with equal or better affinity to the CPD-containing duplex compared with the undamaged duplex. In comparison, MBD does not enhance T=mC CPD formation at a TT mCG site, but instead increases CPD formation at the adjacent TT site. MBD was also found to completely suppress deamination of the T= mCG CPD, suggesting that MeCP2 may have the capability to both suppress UV mutagenesis at PymCpG sites as well as enhance it.
AB - Spontaneous deamination of cytosine to uracil in DNA is a ubiquitous source of C→T mutations, but occurs with a half life of ∼ 50000 years. In contrast, cytosine within sunlight induced cyclobutane dipyrimidine dimers (CPD's), deaminate within hours to days. Methylation of C increases the frequency of CPD formation at PyCG sites which correlate with C→T mutation hotspots in skin cancers. MeCP2 binds to mCG sites and acts as a transcriptional regulator and chromatin modifier affecting thousands of genes, but its effect on CPD formation and deamination is unknown. We report that the methyl CpG binding domain of MeCP2 (MBD) greatly enhances C=mC CPD formation at a TCmCG site in duplex DNA and binds with equal or better affinity to the CPD-containing duplex compared with the undamaged duplex. In comparison, MBD does not enhance T=mC CPD formation at a TT mCG site, but instead increases CPD formation at the adjacent TT site. MBD was also found to completely suppress deamination of the T= mCG CPD, suggesting that MeCP2 may have the capability to both suppress UV mutagenesis at PymCpG sites as well as enhance it.
UR - http://www.scopus.com/inward/record.url?scp=78651295849&partnerID=8YFLogxK
U2 - 10.1093/nar/gkq582
DO - 10.1093/nar/gkq582
M3 - Article
C2 - 20601406
AN - SCOPUS:78651295849
SN - 0305-1048
VL - 38
SP - 6943
EP - 6955
JO - Nucleic acids research
JF - Nucleic acids research
IS - 20
ER -